TOURETTE ASSOCIATION OF AMERICA

Organization · DC
Hires government relations

Who they hire

2024 · 2 filings · Budget/Appropriations, Education, Health Issues, Labor Issues/Antitrust/Workplace, Medicare/Medicaid
$██,███ / qtrUnlock

What they lobby on

Access to Care and Treatment Issues (step therapy, prior authorization, non-medical switching) Medicare Part D Protected Class Drugs, Part D coverage (including out of pocket maximum and smoothing mechanism implementation) Telehealth Coverage
Medicare/Medicaid · 2024 Q1
Diversity, Equity, Inclusion and Accessibility in the Federal Workforce - Executive Order 14035
Labor Issues/Antitrust/Workplace · 2024 Q1
Education Disability Issues, including IDEA Act implementation ESSA (Every Student Succeeds Act) implementation Education needs and experiences of students with Tourette Syndrome, including pell grants and pell grant hour requirement flexibility for students with disabilities including TS
Education · 2024 Q1
Mental Health issues (incl. mental health parity, suicide prevention) General Health Care issues for people living with Tourette Syndrome or other Tic Disorders (preexisting coverage, Medicare/Medicaid) Medicare Part D Protected Class Drugs Coverage, Part D coverage Research, medical and scientific issues (including BRAIN initiative) Access to treatment and care issues (including step therapy, prior authorization, non-medical switching - S. 652/HR2630 Safe Step Act) Pharmacy Benefit Manager Reform Act S.1339 Drug Pricing Broadly Telehealth (including S.2016/HR4189 - Connect for Health Act) Consolidated Appropriations Act of 2023 implementation (HR2617) Inflation Reduction Act Implementation
Health Issues · 2024 Q1
Public Health Education and Research Program on Tourette Syndrome at the Centers for Disease Control and Prevention and CDC Funding Broadly - Fiscal Year 2023, 2024 and 2025 National Institutes of Health (NIH) Medical Research Funding - Fiscal Year 2023, 2024 and 2025 FY2024 Further Consolidated Appropriations Act-H.R. 2882
Budget/Appropriations · 2024 Q1